Evidence map›Paper›PMID 42103068›Full record

ArticleEmerging infectious diseases2026

Emergence of Ceftriaxone-Resistant Neisseria gonorrhoeae penA-60-Carrying Strains, Thailand, 2025.

Rossaphorn Kittiyaowamarn, Pongsathorn Sangprasert, Natnaree Girdthep, Sirintra Pharanut, Tawan Nongpian, Thanakorn Arunngamwong, Ruechakorn Kunkhajornphan, Ismael Maatouk, Magnus Unemo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rossaphorn Kittiyaowamarn
Pongsathorn Sangprasert
Natnaree Girdthep
Sirintra Pharanut
Tawan Nongpian
Thanakorn Arunngamwong
Ruechakorn Kunkhajornphan
Ismael Maatouk
Magnus Unemo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report 5 gonorrhea cases caused by ceftriaxone-resistant penA-60-carrying Neisseria gonorrhoeae bacteria during January-April 2025 in Thailand, successfully cured by ceftriaxone therapy. Most patients had prior over-the-counter antimicrobial drug exposure. Ceftriaxone-resistant gonococcal strains are spreading in Thailand, and strengthened gonorrhea and resistance surveillance and effective antimicrobial stewardship programs are needed.

Indexed as

Anti-Bacterial AgentsCeftriaxoneDrug Resistance, BacterialGonorrheaNeisseria gonorrhoeaeThird Generation CephalosporinsFemaleHumansMaleMicrobial Sensitivity TestsThailandAnti-Bacterial AgentsCeftriaxoneThird Generation Cephalosporinsantimicrobial resistancebacteriabacterial infectionsceftriaxone resistancegonorrheaNeisseria gonorrhoeaepublic healthsexually transmitted infectionsThailand

Identifiers

PMID42103068
PMCPMC13245206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.